Ciprofloxacin NDC 68071-2269

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-2269Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-2269Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-2269-4	68071226904	4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68071-2269-4)Marketed from Sep 28, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ciprofloxacin
Generic name (nonproprietary): ciprofloxacin
Active ingredients: Ciprofloxacin hydrochloride — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076794
Marketing start: Nov 1, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Fluoroquinolones (Chemical structure)
Identifiers: Product ID 68071-2269_1d768e94-f620-944b-e063-6294a90a9549SPL ID 1d768e94-f620-944b-e063-6294a90a9549SPL set ID b064286b-fedc-be68-e053-2995a90aae52RxCUI 309309UNII 4BA73M5E37UPC 0368071226942
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071226904 followed by a unit qualifier and the quantity

Package 68071-2269-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections ( 1.1 ) Bone and Joint Infections ( 1.2 ) Complicated Intra-Abdominal Infections ( 1.3 ) Infectious Diarrhea ( 1.4 ) Typhoid Fever (Enteric Fever) ( 1.5 ) Uncomplicated Cervical and Urethral Gonorrhea ( 1.6 ) Inhalational Anthrax post-exposure in adult and pediatric patients ( 1.7 ) Plague in adult and pediatric patients ( 1.8 ) Chronic Bacterial Prostatitis ( 1.9 ) Lower Respiratory Tract Infections ( 1.10 ) ○ Acute Exacerbation of Chroni…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076794

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076794
Product	Strength	Form · route	Labeler	Product NDC
Ciprofloxacin	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	16252-515
Ciprofloxacin	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals,Inc.	68071-2267